Invention Grant
- Patent Title: Pyridazine compounds as JAK inhibitors
-
Application No.: US15118433Application Date: 2015-02-12
-
Publication No.: US09834548B2Publication Date: 2017-12-05
- Inventor: Qing Xu , Yonghong Song , Anjali Pandey
- Applicant: Portola Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee: Portola Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- International Application: PCT/US2015/015687 WO 20150212
- International Announcement: WO2015/123453 WO 20150820
- Main IPC: C07D417/12
- IPC: C07D417/12 ; C07D237/24 ; C07D409/12 ; C07D401/12 ; C07D403/12 ; C07D401/14 ; C07D403/14 ; C07D409/14 ; C07D405/14
Abstract:
In one aspect, the invention provides a compound according to formula I, as well as tautomers, pharmaceutically acceptable salts, and hydrates thereof. Pharmaceutical compositions, methods of inhibiting Janus kinases (JAKs), and methods for treating a condition or disorder mediated at least in part by JAK kinase activity are also described.
Public/Granted literature
- US20170174673A1 PYRIDAZINE COMPOUNDS AS JAK INHIBITORS Public/Granted day:2017-06-22
Information query
